Sort
25,944 grants matching “neurodegeneration”
ARIA Pathophysiology Characterized by in vivo Neuroimaging, Plasma Biomarkers and Post-Mortem Proteomics
$3,310,951Thomas M Wisniewski · New York University School Of Medicine · U24 · FY2025 · NS
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,310,151John M. Sedivy · Brown University · P01 · FY2022 · AG
Massachusetts Alzheimer's Disease Research Center
$3,306,700Bradley T Hyman · Massachusetts General Hospital · P30 · FY2023 · AG
Massachusetts Alzheimer's Disease Research Center
$3,306,700Bradley T Hyman · Massachusetts General Hospital · P30 · FY2022 · AG
Offspring Study of Mechanisms for Racial Disparities in Alzheimer's Disease
$3,302,462Jennifer Jaie Manly · Columbia University Health Sciences · R01 · FY2025 · AG
Massachusetts Alzheimer's Disease Research Center
$3,298,540Bradley T Hyman · Massachusetts General Hospital · P30 · FY2019 · AG
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration
$3,298,258John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Genetic and clinical studies of Gaucher disease and other lysosomal disorders
$3,290,257Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2025 · HG
Mechanisms of inherited neurodegenerative diseases
$3,289,479Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II
$3,289,394Michael Alosco · Boston University Medical Campus · R01 · FY2024 · NS
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE
$3,286,257Reisa A. Sperling · University Of California, San Diego · U19 · FY2016 · AG
Sphingolipid Biology of Neurodegeneration
$3,274,941Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Mechanisms, modeling and therapies of retinal and macular neurodegeneration
$3,271,791Anand Swaroop · National Eye Institute · ZIA · FY2023 · EY
Olfactory dysfunction as predictor of PM2.5 exposure progression to dementia
$3,264,260Zhekang Ying · University Of Maryland Baltimore · RF1 · FY2025 · AG
Pin1 Regulation in Evolving Alzheimerâs Disease
$3,257,680James S. Malter · Ut Southwestern Medical Center · RF1 · FY2019 · AG
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$3,246,490Berislav V Zlokovic · University Of Southern California · P01 · FY2022 · AG
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,239,892John M. Sedivy · Brown University · P01 · FY2023 · AG
Metformin in Alzheimer's dementia Prevention (MAP)
$3,234,307Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2020 · AG
Diabetes and brain amyloid in middle aged Hispanics
$3,234,050Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2021 · AG
A Systems Approach to Targeting Innate Immunity in AD
$3,233,653Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · U01 · FY2020 · AG
ALZHEIMER'S DISEASE PATHWAYS AND BIOMARKER DISCOVERY BY INTEGRATIVE PROTEOMICS, GLYCOPROTEOMICS, AND GLYCOMICS
$3,232,393Lian Li · Emory University · RF1 · FY2018 · AG
Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease
$3,231,552Arthur W Toga · University Of Southern California · P01 · FY2023 · AG
Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
$3,226,541John M. Sedivy · Brown University · P01 · FY2024 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$3,219,066David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Modulation Of Neuronal Channels and Receptors in the Brain
$3,218,633Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES